FABP4 and systemic sclerosis: A very recent report has also shown that explanted SSc ADSC have profibrotic and anti-adipogenic features, including high levels of the myofibroblast marker α-SMA and low expression of both anti-fibrotic caveolin-1 and the adipogenic marker FABP4 [29].